Common Contracts
4 similar Employment Agreement contracts by Allena Pharmaceuticals, Inc.
EX-10.6 8 d431688dex106.htm EX-10.6 EMPLOYMENT AGREEMENTEmployment Agreement • May 5th, 2020 • Massachusetts
This Employment Agreement (the “Agreement”) is made as of October 17, 2017, between Allena Pharmaceuticals, Inc. (the “Company”), and Edward Wholihan (the “Executive”). This Agreement shall be effective as of the closing of the first underwritten public offering of the equity securities of the Company pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Effective Date”). This Agreement supersedes, amends and restates in all respects any other employment agreements and offer letters between Executive and the Company, including without limitation the Employment Agreement between Executive and the Company dated June 9, 2016 (collectively, the “Superseded Employment Agreements”), except for the Restrictive Covenant Obligations, as defined in Section 8, and that certain Incentive Stock Option Agreement Granted Under 2011 Stock Incentive Plan dated as of September 15, 2016, and attached hereto as Exhibit A, which remain in effect.
EMPLOYMENT AGREEMENTEmployment Agreement • October 23rd, 2017 • Allena Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Massachusetts
This Employment Agreement (the “Agreement”) is made as of October 17, 2017, between Allena Pharmaceuticals, Inc. (the “Company”), and Edward Wholihan (the “Executive”). This Agreement shall be effective as of the closing of the first underwritten public offering of the equity securities of the Company pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Effective Date”). This Agreement supersedes, amends and restates in all respects any other employment agreements and offer letters between Executive and the Company, including without limitation the Employment Agreement between Executive and the Company dated June 9, 2016 (collectively, the “Superseded Employment Agreements”), except for the Restrictive Covenant Obligations, as defined in Section 8, and that certain Incentive Stock Option Agreement Granted Under 2011 Stock Incentive Plan dated as of September 15, 2016, and attached hereto as Exhibit A, which remain in effect.
EMPLOYMENT AGREEMENTEmployment Agreement • October 23rd, 2017 • Allena Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Massachusetts
This Employment Agreement (the “Agreement”) is made as of October 18, 2017, between Allena Pharmaceuticals, Inc. (the “Company”), and Alexey Margolin, Ph.D. (the “Executive”). This Agreement shall be effective as of the closing of the first underwritten public offering of the equity securities of the Company pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Effective Date”). This Agreement supersedes, amends and restates in all respects any other employment agreements and offer letters between Executive and the Company, including without limitation the Employment Agreement between Executive and the Company dated June 19, 2014, as amended effective July 1, 2016 and June 30, 2017 (collectively, the “Superseded Employment Agreements”), except for the Restrictive Covenant Obligations, as defined in Section 8, and (i) those certain Incentive Stock Option Agreements Granted Under 2011 Stock Incentive Plan dated as of March 5, 2014; May 15, 201
EMPLOYMENT AGREEMENTEmployment Agreement • October 23rd, 2017 • Allena Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Massachusetts
This Employment Agreement (the “Agreement”) is made as of October 19, 2017, between Allena Pharmaceuticals, Inc. (the “Company”), and Louis Brenner, M.D. (the “Executive”). This Agreement shall be effective as of the closing of the first underwritten public offering of the equity securities of the Company pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Effective Date”). This Agreement supersedes, amends and restates in all respects any other employment agreements and offer letters between Executive and the Company, including without limitation the Employment Agreement between Executive and the Company dated March 17, 2015 (collectively, the “Superseded Employment Agreements”), except for the Restrictive Covenant Obligations, as defined in Section 8, and that certain Incentive Stock Option Agreements Granted Under 2011 Stock Incentive Plan dated as of June 18, 2015, March 10, 2016 and February 26, 2017 and attached hereto as Exhibit A,
